Armond Wilson partners Monica Arnold and Michelle Armond are back with the latest installment of their year-end column ...
July 10, 2025 - Patent Trial and Appeal Board (PTAB) post-grant validity challenges — for example, inter partes review — are frequent components of a patent litigation strategy for defendants.
April 17, 2023 - Patent Trial and Appeal Board (PTAB) post-grant validity challenges — for example, inter partes review — are frequent components of a patent litigation strategy for defendants.
Since they first became available in September 2012, inter partes review proceedings continue to gain popularity as a means of challenging the validity of patents. While IPRs have had the most impact ...
“Your client’s litigation campaign hopefully involves the assertion of multiple patents, not just one or two, to have a good opportunity to escape the IPR process with at least a few confirmed claims.
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Mara Renewables Corporation, and its manufacturing partner Algal Omega-3 (AO3), announced today they have filed an IPR in the United States on DSM Patent No.
The US Federal Circuit has imposed restrictions on who can appeal against an inter partes review decision, making life difficult for some petitioners. However, there are some practical tips to ...
The year 2025 was one of profound change at the U.S. Patent and Trademark Office (USPTO). The magnitude and rate at which changes were implemented is unprecedented.
ANDOVER, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Vicor Corporation (VICR) today announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback